GENESEEQ
Established in 2008, Geneseeq is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine. Geneseeq’s world-leading laboratories have successfully passed China’s National Center of Clinical Laboratories(NCCL) External Quality Assessment(EQA), College of American Pathologists(CAP) PT, European Molecular Genetics Quality Network(EMQN) PT, and received 3rd party medical laboratory and clinical PCR amplification laboratory qualifications.
GENESEEQ
Industry:
Biotechnology Clinical Trials Health Care Life Science
Founded:
2008-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.na.geneseeq.com
Total Employee:
11+
Status:
Active
Contact:
400-636-2325
Email Addresses:
[email protected]
Total Funding:
135.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Employees Featured
Founder
Investors List
SBCVC
SBCVC investment in Series D - Geneseeq
China Reform Holdings Corporation
China Reform Holdings Corporation investment in Series D - Geneseeq
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - Geneseeq
Industrial Securities Capital
Industrial Securities Capital investment in Series C - Geneseeq
Huatai Health Fund
Huatai Health Fund investment in Series C - Geneseeq
Cowin Capital
Cowin Capital investment in Series C - Geneseeq
Boyuanhongsheng
Boyuanhongsheng investment in Series C - Geneseeq
Huatai Securities
Huatai Securities investment in Series C - Geneseeq
DNV capital
DNV capital investment in Series B - Geneseeq
Beijing Beilu Pharmaceutical
Beijing Beilu Pharmaceutical investment in Series B - Geneseeq
Official Site Inspections
http://www.na.geneseeq.com
- Host name: 175.82.208.35.bc.googleusercontent.com
- IP address: 35.208.82.175
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
